Santa Cruz Biotechnology supplies a comprehensive collection of GMPS Antibodies for investigating guanosine monophosphate synthase (GMPS) in cellular processes. GMPS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GMPS is a critical enzyme involved in the de novo synthesis of guanine nucleotides, which are essential for DNA and RNA synthesis, as well as for cellular signaling pathways. GMPS plays a vital role in cell proliferation and survival, making it an important target in studies related to cancer and other proliferative diseases. Understanding GMPS activity can provide insights into metabolic regulation and potential therapeutic interventions. Researchers worldwide rely on GMPS monoclonal antibodies to explore cellular mechanisms and pathways. GMPS research continues to reveal new insights into cellular metabolism and disease progression. Investigating GMPS function has led to significant discoveries in cancer biology and therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for GMPS support researchers in advancing scientific understanding of cellular processes and disease mechanisms.